Literature DB >> 12483758

A utility-theoretic model for QALYs and willingness to pay.

Thomas Klose1.   

Abstract

Despite the widespread use of quality-adjusted life years (QALY) in economic evaluation studies, their utility-theoretic foundation remains unclear. A model for preferences over health, money, and time is presented in this paper. Under the usual assumptions of the original QALY-model, an additive separable presentation of the utilities in different periods exists. In contrast to the usual assumption that QALY-weights do solely depend on aspects of health-related quality of life, wealth-standardized QALY-weights might vary with the wealth level in the presented extension of the original QALY-model resulting in an inconsistent measurement of QALYs. Further assumptions are presented to make the measurement of QALYs consistent with lifetime preferences over health and money. Even under these strict assumptions, QALYs and WTP (which also can be defined in this utility-theoretic model) are not equivalent preference-based measures of the effects of health technologies on an individual level. The results suggest that the individual WTP per QALY can depend on the magnitude of the QALY-gain as well as on the disease burden, when health influences the marginal utility of wealth. Further research seems to be indicated on this structural aspect of preferences over health and wealth and to quantify its impact. Copyright 2002 John Wiley & Sons, Ltd.

Mesh:

Year:  2003        PMID: 12483758     DOI: 10.1002/hec.697

Source DB:  PubMed          Journal:  Health Econ        ISSN: 1057-9230            Impact factor:   3.046


  6 in total

1.  Long-term quality-of-life assessment after laparoscopic and classic cholecystectomy.

Authors:  A Lachinski; A Vingerhoets; M Markuszewska-Proczko; T Stefaniak
Journal:  Surg Endosc       Date:  2004-05-12       Impact factor: 4.584

2.  A game-theoretic framework for estimating a health purchaser's willingness-to-pay for health and for expansion.

Authors:  Reza Yaesoubi; Stephen D Roberts
Journal:  Health Care Manag Sci       Date:  2010-08-12

3.  Discounting health effects in pharmacoeconomic evaluations: current controversies.

Authors:  J M Bos; Maarten J Postma; Lieven Annemans
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

4.  Can hospitals compete on quality? Hospital competition.

Authors:  Somayeh Sadat; Hossein Abouee-Mehrizi; Michael W Carter
Journal:  Health Care Manag Sci       Date:  2015-02-25

5.  Willingness to pay for a quality-adjusted life year: a systematic review with meta-regression.

Authors:  Christian R C Kouakou; Thomas G Poder
Journal:  Eur J Health Econ       Date:  2021-08-21

6.  Managing incidental pancreatic cystic neoplasms with integrated molecular pathology is a cost-effective strategy.

Authors:  Ananya Das; William Brugge; Girish Mishra; Dennis M Smith; Mankanwal Sachdev; Eric Ellsworth
Journal:  Endosc Int Open       Date:  2015-06-26
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.